Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
mafenidacetat 85 mg/g creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
mafenidacetat 5 % opløsning, pulver til rekonstitution |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
sulfacetamid 10 % lotion |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely sulconazole nitrate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
butenafinhydrochlorid 1 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
haloprogin 1 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Haloprogin 10 mg/mL cutaneous solution |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
oxiconazolnitrat 1 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
oxiconazolnitrat 1 % lotion |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
clioquinol 3 % + hydrocortison 0,5 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
naftifinhydrochlorid 1 % gel |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
iodoquinol 1 % + hydrocortison 1 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
scopolamin 0,5 mg/24-timer plaster |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
nitroglycerin 0,6 mg/time |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
nitroglycerin 0,1 mg/time |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
nitroglycerin 0,2 mg/time |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
nitroglycerin 0,4 mg/time |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Alitretinoin 0,1 % gel |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
monobenzon 20 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely methoxsalen 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Hexachlorophene 30 mg/mL cutaneous emulsion |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely Podophyllum resin 250 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
methoxsalen 20 µg/ml injektionsvæske, opløsning |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
methoxsalen 10 mg/ml lotion |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
cantharidin 0,7 % væske |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Glycerylnitrat-depotplaster 5 mg/24 timer |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Glycerylnitrat-depotplaster 7 mg/24 timer |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Glycerylnitrat-depotplaster 10 mg/24 timer |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
scopolamin plaster a 1,5 mg/enhed |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
hexachlorophen 3% sæbe |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely becaplermin 100 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
halobetasolpropionat 0,05 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
halobetasolpropionat 0,05 % salve |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely chloroxine 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
podofilox 0,5 % gel til topikal anvendelse |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
mafenidacetat 112 mg creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
mafenidacetat 5 % pulver |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
betamethasonvalerat 0,12 % aerosol |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Amphotericin B 30 mg/mL cutaneous cream |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
naftifinhydrochlorid 1,0 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Amcinonide 1 mg/mL cutaneous cream |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
diflorasondiacetat 0,5 mg salve |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely diflorasone diacetate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
gentamicinsulfat 1 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
gentamicinsulfat 0,1 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Calcipotriene hydrate 0.005% cream |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
clindamycinphosphat 1 % opløsning til topikal anvendelse |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
flurandrenolid 4 µg, depotplaster |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Fludroxycortide 500 microgram/mL cutaneous lotion |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
hydroquinon 30 mg opløsning |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely hydroquinone 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
hydroquinon 4 % gel |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Anthralin 0.25% topical cream |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Hydrocortisone valerate 2 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
betamethasondipropionat 0,05 % lotion |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
betamethasondipropionat 0,05 % gel |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
lidocainhydrochlorid 4 % opløsning |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
betamethasondipropionat 0,5 mg/g creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
betamethasondipropionat 0,5 mg/g salve |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
clonidin 2,5 mg/enhed |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
betamethasondipropionat 0,5 mg creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
betamethasondipropionat 0,5 % salve |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
benzoylperoxid 10 % |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Triamcinolone acetonide 1 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Triamcinolone acetonide 250 microgram/mL cutaneous cream |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely triamcinolone acetonide 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
hydrocortisonacetat 30 mg |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
benzoylperoxid 4 % lotion |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
benzoylperoxid 3 % gel |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
benzoylperoxid 4 % gel |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
benzoylperoxid 8 % gel |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
benzoylperoxid 8 % lotion |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
benzoylperoxid 8 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
benzoylperoxid 10 % creme |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
benzoylperoxid 5 % skyllevæske til topikal anvendelse |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
benzoylperoxid 6 % gel |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
adapalen 0,1 % opløsning |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Tretinoin 1 mg/g cutaneous gel |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Tretinoin 1 mg/mL cutaneous cream |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Calcipotriene 0.005% solution |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Calcipotriene 0.005% ointment |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
dexamethason 10 mg/25 g |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Nystatin 100 unit/mg cutaneous powder |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Fluocinonide 500 microgram/g cutaneous gel |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely fluocinonide 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Desonide 500 microgram/mL cutaneous cream |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|
Desonide 500 microgram/g cutaneous ointment |
Has manufactured dose form |
False |
kutan OG/ELLER transdermal doseringsform |
Inferred relationship |
Some |
|